clopidogrel 75 MG Oral Tablet
1. INDICATIONS AND USAGE Clopidogrel tablets are a P2Y 12 platelet inhibitor indicated for: Acute coronary syndrome - For patients with non-ST-segment elevation ACS (unstable angina [UA]/non-ST-elevation myocardial infarction [NSTEMI]), clopidogrel tablets have been shown to reduce the rate of myocardial infarction (MI) and stroke. ( 1.1 ) - For patients with ST-elevation myocardial infarction (STEMI), clopidogrel tablets have been shown to reduce the rate of MI and stroke. ( 1.1 ) Recent MI, recent stroke, or established peripheral arterial disease. Clopidogrel tablets have been shown to reduce the rate of MI and stroke. ( 1.2 ) 1.1 Acute Coronary Syndrome (ACS) Clopidogrel tablets are indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS (unstable angina [UA]/non-ST-elevation myocardial infarction [NSTEMI]), including patients who are to be managed medically and those who are to be managed with coronary revascularization. Clopidogrel tablets should be administered in conjunction with aspirin. Clopidogrel tablets are indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI) who are to be managed medically. Clopidogrel tablets should be administered in conjunction with aspirin. 1.2 Recent MI, Recent Stroke, or Established Peripheral Arterial Disease In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke clopidogrel tablets are indicated to reduce the rate of MI and stroke.
Accord Healthcare Inc.
ROUND PINK CI
CI ROUND PINK
Related Pills
clopidogrel 75 MG Oral Tablet
Accord Healthcare Inc.
Diethylpropion Hydrochloride 24 HR Diethylpropion Hydrochloride 75 MG Extended Release Oral Tablet
A-S Medication Solutions LLC
Diethylpropion Hydrochloride 24 HR Diethylpropion Hydrochloride 75 MG Extended Release Oral Tablet
Preferred Pharmaceuticals, Inc.
meloxicam 15 mg
Cipla USA Inc.
Baclofen Baclofen 10 MG Oral Tablet
Lannett Company, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Clopidogrel tablets USP 75 mg are available as pink colored, round, biconvex, film coated tablets debossed with "CI" on one side and plain on other side. Tablets are provided as follows: NDC 16729-218-10 Bottles of 30 count comes in child-resistant package NDC 16729-218-15 Bottles of 90 count comes in child-resistant package NDC 16729-218-16 Bottles of 500 count comes in child-resistant package NDC 16729-218-46 Blisters of 100 count Clopidogrel tablets USP 300 mg are available as pink colored, oval, biconvex, beveled edged, film coated tablets debossed with "CL" on one side and plain on other side. Tablets are provided as follows: NDC 16729-219-75 Blisters of 30 count NDC 16729-219-46 Blisters of 100 count Store at 25° C (77° F); excursions permitted to 15°C to 30° C (59°F to 86° F) [see USP Controlled Room Temperature].
More pills like ROUND CI